Literature DB >> 30431421

Fosfomycin: mechanisms and the increasing prevalence of resistance.

Mina Aghamali1, Mansour Sedighi2, Abed Zahedi Bialvaei2, Nima Mohammadzadeh2, Sara Abbasian2, Zahra Ghafouri3, Ebrahim Kouhsari2.   

Abstract

There are challenges regarding increased global rates of microbial resistance and the emergence of new mechanisms that result in microorganisms becoming resistant to antimicrobial drugs. Fosfomycin is a broad-spectrum bactericidal antibiotic effective against Gram-negative and certain Gram-positive bacteria, such as Staphylococci, that interfere with cell wall synthesis. During the last 40 years, fosfomycin has been evaluated in a wide range of applications and fields. Although numerous studies have been done in this area, there remains limited information regarding the prevalence of resistance. Therefore, in this review, we focus on the available data concerning the mechanisms and increasing resistance regarding fosfomycin.

Entities:  

Keywords:  Fosfomycin; Fosfomycin–Trometamol; antibiotic; resistance; urinary tract infections

Mesh:

Substances:

Year:  2018        PMID: 30431421     DOI: 10.1099/jmm.0.000874

Source DB:  PubMed          Journal:  J Med Microbiol        ISSN: 0022-2615            Impact factor:   2.472


  15 in total

Review 1.  Differences in Fosfomycin Resistance Mechanisms between Pseudomonas aeruginosa and Enterobacterales.

Authors:  Dina Zheng; Phillip J Bergen; Cornelia B Landersdorfer; Elizabeth B Hirsch
Journal:  Antimicrob Agents Chemother       Date:  2021-11-22       Impact factor: 5.938

Review 2.  Potential Inhibitors Targeting Escherichia coli UDP-N-Acetylglucosamine Enolpyruvyl Transferase (MurA): An Overview.

Authors:  Diksha Raina; Chetan Kumar; Vinod Kumar; Inshad Ali Khan; Saurabh Saran
Journal:  Indian J Microbiol       Date:  2021-10-29       Impact factor: 2.461

3.  Evaluation of the Synergistic Antibacterial Effects of Fosfomycin in Combination with Selected Antibiotics against Carbapenem-Resistant Acinetobacter baumannii.

Authors:  Ozioma F Nwabor; Pawarisa Terbtothakun; Supayang P Voravuthikunchai; Sarunyou Chusri
Journal:  Pharmaceuticals (Basel)       Date:  2021-02-25

4.  Methylation analysis of Klebsiella pneumoniae from Portuguese hospitals.

Authors:  Anton Spadar; João Perdigão; Jody Phelan; James Charleston; Ana Modesto; Rita Elias; Paola Florez de Sessions; Martin L Hibberd; Susana Campino; Aida Duarte; Taane G Clark
Journal:  Sci Rep       Date:  2021-03-22       Impact factor: 4.379

5.  Characterization of fosfomycin resistance and molecular epidemiology among carbapenem-resistant Klebsiella pneumoniae strains from two tertiary hospitals in China.

Authors:  Haichen Wang; Changhang Min; Jun Li; Ting Yu; Yongmei Hu; Qingya Dou; Mingxiang Zou
Journal:  BMC Microbiol       Date:  2021-04-11       Impact factor: 3.605

6.  The Impact of the Antibiotic Fosfomycin on Wastewater Communities Measured by Flow Cytometry.

Authors:  Shuang Li; Zishu Liu; Christine Süring; Luyao Chen; Susann Müller; Ping Zeng
Journal:  Front Microbiol       Date:  2022-03-03       Impact factor: 5.640

7.  Prevalence of fosfomycin resistance and gene mutations in clinical isolates of methicillin-resistant Staphylococcus aureus.

Authors:  Yi-Chien Lee; Pao-Yu Chen; Jann-Tay Wang; Shan-Chwen Chang
Journal:  Antimicrob Resist Infect Control       Date:  2020-08-17       Impact factor: 4.887

8.  Novel Chromosomal Mutations Responsible for Fosfomycin Resistance in Escherichia coli.

Authors:  Vincent Cattoir; Annabelle Pourbaix; Mélanie Magnan; Françoise Chau; Victoire de Lastours; Brice Felden; Bruno Fantin; François Guérin
Journal:  Front Microbiol       Date:  2020-10-20       Impact factor: 5.640

9.  The Genomic Characterization of KPC-Producing Klebsiella pneumoniae from the ICU of a Teaching Hospital in Shanghai, China.

Authors:  Yingying Du; Shikui Mu; Yan Liu; Yinghua Yuan; Yunlou Zhu; Lijie Ma; Qixing Wang; Zhengfang Zhu; Yuhao Liu; Sheng Wang
Journal:  Infect Drug Resist       Date:  2022-01-11       Impact factor: 4.003

10.  Potential of MurA Enzyme and GBAP in Fsr Quorum Sensing System as Antibacterial Drugs Target: In vitro and In silico Study of Antibacterial Compounds from Myrmecodia pendans.

Authors:  Eti Apriyanti; Mieke H Satari; Dikdik Kurnia
Journal:  Comb Chem High Throughput Screen       Date:  2021       Impact factor: 1.339

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.